Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toxic epidermal necrolysis (TEN) in elderly patients.
Honari S, Gibran NS, Heimbach DM, Gibbons J, Pharmd, Cain V, Engrav LH. Honari S, et al. Among authors: cain v. J Burn Care Rehabil. 2001 Mar-Apr;22(2):132-5. doi: 10.1097/00004630-200103000-00009. J Burn Care Rehabil. 2001. PMID: 11302601
Sleep disturbance after burn injury.
Boeve SA, Aaron LA, Martin-Herz SP, Peterson A, Cain V, Heimbach DM, Patterson DR. Boeve SA, et al. Among authors: cain v. J Burn Care Rehabil. 2002 Jan-Feb;23(1):32-8. doi: 10.1097/00004630-200201000-00007. J Burn Care Rehabil. 2002. PMID: 11803310
Improved burn scar assessment with use of a new scar-rating scale.
Yeong EK, Mann R, Engrav LH, Goldberg M, Cain V, Costa B, Moore M, Nakamura D, Lee J. Yeong EK, et al. Among authors: cain v. J Burn Care Rehabil. 1997 Jul-Aug;18(4):353-5; discussion 352. doi: 10.1097/00004630-199707000-00014. J Burn Care Rehabil. 1997. PMID: 9261704
Burn care. The rehab guide.
Johnson CL, Cain VJ. Johnson CL, et al. Among authors: cain vj. Am J Nurs. 1985 Jan;85(1):48-50. Am J Nurs. 1985. PMID: 3843920 No abstract available.
Data from a pooled post hoc analysis of 14 placebo-controlled, dapagliflozin treatment studies in patients with type 2 diabetes with and without anemia at baseline.
Stefánsson BV, Heerspink HJL, Wheeler DC, Sjöström CD, Greasley PJ, Sartipy P, Cain V, Correa-Rotter R. Stefánsson BV, et al. Among authors: cain v. Data Brief. 2021 Jun 21;37:107237. doi: 10.1016/j.dib.2021.107237. eCollection 2021 Aug. Data Brief. 2021. PMID: 34258337 Free PMC article.
Correction of anemia by dapagliflozin in patients with type 2 diabetes.
Stefánsson BV, Heerspink HJL, Wheeler DC, Sjöström CD, Greasley PJ, Sartipy P, Cain V, Correa-Rotter R. Stefánsson BV, et al. Among authors: cain v. J Diabetes Complications. 2020 Dec;34(12):107729. doi: 10.1016/j.jdiacomp.2020.107729. Epub 2020 Sep 5. J Diabetes Complications. 2020. PMID: 32948397
The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis.
Scholtes RA, van Raalte DH, Correa-Rotter R, Toto RD, Heerspink HJL, Cain V, Sjöström CD, Sartipy P, Stefánsson BV. Scholtes RA, et al. Among authors: cain v. Diabetes Obes Metab. 2020 Apr;22(4):549-556. doi: 10.1111/dom.13923. Epub 2019 Dec 14. Diabetes Obes Metab. 2020. PMID: 31742881 Free PMC article.
72 results